We further explored whether the faecal microbiota play potential roles in the progression of anti-TB drug-induced liver injury (ATDILI) to provide novel ideas about individualized diagnostics, prevent
Table S1. Search strategies and results Table S2. Quality assessment of the included studies (NOS) Figure S1. Forest plot of AT-DILI risk associated with rs2001350 polymorphism in NFE2L2 of Nrf2/ARE p
Characteristics of microbiota changes in tuberculosis patients before and after anti-tuberculosis treatment, and microbiota features associated with hepatotoxicity induced by isoniazid, rifampicin, an
